Type II NKT Cells: An Elusive Population With Immunoregulatory Properties

被引:71
|
作者
Singh, Avadhesh Kumar [1 ]
Tripathi, Prabhanshu [1 ,2 ]
Cardell, Susanna L. [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden
[2] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Ctr Human Microbial Ecol, Faridabad, India
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
基金
瑞典研究理事会;
关键词
type II NKT cells; CD1d; sulfatide; T cell receptor; health and disease; KILLER T-CELLS; INFLAMMATORY-LIVER-DISEASE; HEPATITIS-B-VIRUS; NONOBESE DIABETIC MICE; ADIPOSE-TISSUE; CUTTING EDGE; MEDIATED ACTIVATION; ULCERATIVE-COLITIS; MICROBIAL IMMUNITY; INSULIN-RESISTANCE;
D O I
10.3389/fimmu.2018.01969
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer T (NKT) cells are unique unconventional T cells that are reactive to lipid antigens presented on the non-polymorphic major histocompatibility class (MHC) I-like molecule CD1d. They have characteristics of both innate and adaptive immune cells, and have potent immunoregulatory roles in tumor immunity, autoimmunity, and infectious diseases. Based on their T cell receptor (TCR) expression, NKT cells are divided into two subsets, type I NKT cells with an invariant TCR alpha-chain (V alpha 24 in humans, V alpha 14 in mice) and type II NKT cells with diverse TCRs. While type I NKT cells are well-studied, knowledge about type II NKT cells is still limited, and it is to date only possible to identify subsets of this population. However, recent advances have shown that both type I and type II NKT cells play important roles in many inflammatory situations, and can sometimes regulate the functions of each other. Type II NKT cells can be both protective and pathogenic. Here, we review current knowledge on type II NKT cells and their functions in different disease settings and how these cells can influence immunological outcomes.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] The immunoregulatory role of type I and type II NKT cells in cancer and other diseases
    Masaki Terabe
    Jay A. Berzofsky
    Cancer Immunology, Immunotherapy, 2014, 63 : 199 - 213
  • [2] The immunoregulatory role of type I and type II NKT cells in cancer and other diseases
    Terabe, Masaki
    Berzofsky, Jay A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (03) : 199 - 213
  • [3] Immunoregulatory role of NKT cells
    Lehuen, A
    Laloux, V
    Novak, J
    Beaudoin, L
    COELIAC DISEASE, 2003, : 83 - 87
  • [4] A resident immunoregulatory NKT cell population in the thymus
    Berzins, SP
    McNab, F
    Pellicci, D
    Kyparissoudis, K
    Field, K
    Smyth, M
    Godfrey, DI
    TISSUE ANTIGENS, 2005, 66 (05): : 361 - 361
  • [5] Type II NKT cells suppress tumor immunosurveillance enhanced by type I NKT cells
    Terabe, Masaki
    Ambrosino, Elena
    Takaku, Shun
    Peng, Judy
    Miyake, Sachiko
    Halder, Ramesh
    Yamamura, Takashi
    Kumar, Vipin
    Berzofsky, Jay
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [6] Langerhans Cells Serve as Immunoregulatory Cells by Activating NKT Cells
    Fukunaga, Atsushi
    Khaskhely, Noor M.
    Ma, Ying
    Sreevidya, Coimbatore S.
    Taguchi, Kumiko
    Nishigori, Chikako
    Ullrich, Stephen E.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (08): : 4633 - 4640
  • [7] Langerhans cells serve as immunoregulatory cells by activating NKT cells
    Fukunaga, A.
    Khaskhley, N. M.
    Sreevidya, C. S.
    Ullrich, S. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S158 - S158
  • [8] NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis
    Terabe, Masaki
    Berzofsky, Jay A.
    TRENDS IN IMMUNOLOGY, 2007, 28 (11) : 491 - 496
  • [9] Type II NKT Cells and Their Emerging Role in Health and Disease
    Dhodapkar, Madhav V.
    Kumar, Vipin
    JOURNAL OF IMMUNOLOGY, 2017, 198 (03): : 1015 - 1021
  • [10] Indentification of novel ligands that alter the function of type II NKT cells
    Nishio, Kumiko
    Camara, Kaddy
    Pasquet, Lise
    Bloom, Anja C.
    Richardson, Stewart K.
    Cardell, Susanna L.
    Howell, Amy R.
    Terabe, Masaki
    Olkhanud, Purevdorj
    Berzofsky, Jay A.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):